id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ihlr-21707	Brown, Benjamin E.	Decreasing Prescription Drug Prices: Can Effective Policy Incentivize Cooperation Between Previously Antithetic Sectors?	2017	31	.pdf	application/pdf	1500	49	29	The Legal Landscape For Reverse Payment Settlements After Federal Trade Commission v. Actavis, Inc. Id. Id. See supra B. Patent and Antitrust Laws See generally Pharmaceutical Industry Pharmaceutical Industry supra Pharmaceutical Industry supra Pharmaceutical Antitrust: Delayed Generic Entry Cases Frequently Asked Questions on Patents and Exclusivity Pharmaceutical Corporations and Medical Research Drug Patent Expirations and the “Patent Cliff” supra Id. C. Generic Pharmaceutical Company Issues Prescriptions For Change: The Hatch-Waxman Act And New Legislation To Increase The Availability Of Generic Drugs To Consumers supra Drug Prices Defy Gravity, Doubling or Dozens of Products, The Industry Id. Be Wary of Stratospheric Increases in Generic Drug Prices, Id. Id. Expose Reveals Why We No Longer Trust All Generic Drugs D. Increased Marketing Expenditures Detailing How a Cabal Keeps Generics Scarce supra see also, , supra There Ain’t No Such Thing as a Free Lunch: A Look at State Disclosure Laws and the Effect on Pharmaceutical Company Marketing see also Big Bad Pharma: An Ethical Analysis of Physician-Directed and Consumer-Directed Marketing Tactics The Impact of Direct-to-Consumer Advertising Big Bad Pharma: An Ethical Analysis of Physician-Directed and Consumer-Directed Marketing Tactics Id. Sorrell v. IMS Health See generally Health Care Costs: A Primer Pharmaceutical Detailing Definition supra The Pharma Marketing Glossary Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients Pharmaceutical Detailing Is Not For Everyone: Side Effects May Include Sub-Optimal Prescribing Decisions, Compromised Patient Health, And Increased Prescription Drug Spending supra Regulating Pharmaceutical Marketing Economic Repurposing of Drugs Id. See generally supra supra See generally The Cost Of Creating A New Drug Now $5 Billion, Pushing Big Pharma To Change supra See generally Definition of a Private Operating Foundation supra Id. Id. See generally supra supra C. Example: Cystic Fibrosis Foundation Collaboration with Vertex Pharmaceuticals PhRMA	cache/ihlr-21707.pdf	txt/ihlr-21707.txt